H.R. 6009 · 119th Congress · Armed Forces and National Security
Defense Biotechnology Strategy Act
- IntroducedNov 10, 2025 Done
- CommitteeReferred to 2 committees Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
Became law inside another bill: its text was enacted in S. 1071 (National Defense Authorization Act for Fiscal Year 2026), signed Dec 18, 2025. The bar shows how far this bill got under its own number.
Full text
No CRS summary yet · 375 wordsH.R. 6009 · Introduced in House · Nov 10, 2025
This Act may be cited as the Defense Biotechnology Strategy Act .
(a) In general. Not later than 1 year after the date of enactment of this Act, the Secretary of Defense shall, in coordination with the Under Secretary of Defense for Research and Engineering and the Under Secretary of Defense for Acquisition and Sustainment, submit to the Committee on Armed Services of the Senate and the Committee on Armed Services of the House of Representatives a strategy on the national security implications of emerging biotechnologies, including the future role that biotechnology will play in defense, and means to improve industry, interagency, and international relationships in this sector.
(b) Elements. The strategy required pursuant to subsection (a) shall include the following elements: (1) How the Department of Defense will develop and expand a network of commercial facilities for the biomanufacture of products that are critical for defense needs. (2) Review and update of military specifications in order to better incorporate or substitute current products with biotechnology-based products. (3) Updated plans and policies for the Department to enter into advance market commitments and offtake agreements for biotechnology products that have defense applications. (4) A description of how the Department could better incorporate military-relevant applications of emerging biotechnology into wargaming exercises, tabletop exercises, or other net assessment analyses. (5) The benefits and costs of issuing a research grand challenge, or a series of challenges, that focus on making biotechnology predictably engineerable and how the Department would implement such research grand challenge, or challenges. (6) Development of a biotechnology regulation science and technology program within the Department, including development of digital infrastructure to support simplified regulation and the development of biometrology tools. (7) Updated plans and policies for inter-governmental support that the Department could provide in encouraging member countries of the North Atlantic Treaty Organization (NATO) to aggregate demand and pool purchasing power for biotechnology products. (8) Review of plans and guidance on how the Department can work to develop, integrate, and disseminate biotechnology research initiatives across member countries of the North Atlantic Treaty Organization, and how the Department might coordinate with international stakeholders to utilize the combined research capabilities of such member countries to drive a biotechnology development approach.
Shown here because the text is under 500 words. Open on Congress.gov
Who lobbies on it
1 organization · 4 filings · Q4 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Enbridge (u.s.) Inc
4 of 4 quarters
“…H.R. 6009 - (118), Restoring American Energy Dominance Act H.R. 6494 - Promoting Innovation in Pipeline Efficiency and Safety (PIPES) Act of 2023 H.R. 3699 - Energy Choice Act H.R. 4758 - Homeowner Energy Freedom Act H.R. 4626 - Dont Mess With My Home Appliances Act H.R. 7024 - Tax Relief for American Families and…”
$1.0M lobbying spend in 2026 to date, all issuesQ3 2026 filing
Organizations that named H.R. 6009 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Nov 10, 2025Referred to the Committee on Armed Services, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Nov 10, 2025Introduced in House